Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis-Reference-Cited by-同舟云学术

Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis

Published:2020-01 Issue:1 Volume:77 Page:3-10
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Sandler Kiri A.,Cook Ryan R.,Ciezki Jay P.,Ross Ashley E.,Pomerantz Mark M.,Nguyen Paul L.,Shaikh Talha,Tran Phuoc T.,Stock Richard G.,Merrick Gregory S.,Demanes David Jeffrey,Spratt Daniel E.,Abu-Isa Eyad I.,Wedde Trude B.,Lilleby Wolfgang,Krauss Daniel J.,Shaw Grace K.,Alam Ridwan,Reddy Chandana A.,Song Daniel Y.,Klein Eric A.,Stephenson Andrew J.,Tosoian Jeffrey J.,Hegde John V.,Yoo Sun Mi,Fiano Ryan,D’Amico Anthony V.,Nickols Nicholas G.,Aronson William J.,Sadeghi Ahmad,Greco Stephen C.,Deville Curtiland,McNutt Todd,DeWeese Theodore L.,Reiter Robert E.,Said Jonathan W.,Steinberg Michael L.,Horwitz Eric M.,Kupelian Patrick A.,King Christopher R.,Kishan Amar U.

Publisher

Elsevier BV

Subject

Urology

Reference35 articles.

1. Targeting pelvic lymph nodes in men with intermediate- and high-risk prostate cancer despite two negative randomized trials;Nguyen;J Clin Oncol,2008

2. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413;Roach;J Clin Oncol,2003

3. An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions;Lawton;Int J Radiat Oncol Biol Phys,2007

4. Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial;Roach;Lancet Oncol,2018

5. Pelvic nodal radiotherapy in patients with unfavorable intermediate and high-risk prostate cancer: evidence, rationale, and future directions;Morikawa;Int J Radiat Oncol Biol Phys,2011

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Moderately hypofractionated prostate-only versus whole-pelvis radiotherapy for high-risk prostate cancer: A retrospective real-world single-center cohort study;Clinical and Translational Radiation Oncology;2024-09

2. Weekly ultra-hypofractionated radiotherapy in localised prostate cancer;Clinical and Translational Radiation Oncology;2024-07

3. Prostate cancer and elective nodal radiation therapy for cN0 and pN0—a never ending story?;Strahlentherapie und Onkologie;2024-01-25

4. A Randomized Feasibility Trial of Stereotactic Prostate Radiation Therapy With or Without Elective Nodal Irradiation in High-Risk Localized Prostate Cancer (SPORT Trial);International Journal of Radiation Oncology*Biology*Physics;2023-11

5. Feasibility of simultaneous integrated boost for high-dose treatment of high-risk prostate cancer;Siberian journal of oncology;2023-06-29